Functional interaction between tumor suppressor menin and activator of S-phase kinase

Multiple endocrine neoplasia type I (MEN1), a hereditary tumor syndrome, is characterized by the development of tumors in multiple endocrine organs. The gene mutated in MEN1 patients, Men1, encodes a tumor suppressor, menin. Overexpression of menin leads to inhibition of Ras-transformed cells. Howev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2004-09, Vol.64 (18), p.6791-6796
Hauptverfasser: SCHNEPP, Robert W, ZHAOYUAN HOU, HAOREN WANG, PETERSEN, Clark, SILVA, Albert, MASAI, Hisao, XIANXIN HUA
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6796
container_issue 18
container_start_page 6791
container_title Cancer research (Chicago, Ill.)
container_volume 64
creator SCHNEPP, Robert W
ZHAOYUAN HOU
HAOREN WANG
PETERSEN, Clark
SILVA, Albert
MASAI, Hisao
XIANXIN HUA
description Multiple endocrine neoplasia type I (MEN1), a hereditary tumor syndrome, is characterized by the development of tumors in multiple endocrine organs. The gene mutated in MEN1 patients, Men1, encodes a tumor suppressor, menin. Overexpression of menin leads to inhibition of Ras-transformed cells. However, it is unclear whether menin is essential for repression of cell proliferation, and if it is, how it inhibits cell proliferation. Here, we show that targeted disruption of the Men1 gene leads to enhanced cell proliferation, whereas complementation of menin-null cells with menin reduces cell proliferation. Moreover, menin interacts with activator of S-phase kinase (ASK), a component of the Cdc7/ASK kinase complex that is crucial for cell proliferation, but does not appear to alter Cdc7 kinase activity in in vitro kinase assays. We identify the COOH terminus of menin as the domain that mediates the specific interaction with ASK. Notably, wild-type menin completely represses ASK-induced cell proliferation, although it does not obviously affect the steady-state cell cycle profile of ASK-infected cells. Interestingly, disease-related COOH-terminal menin mutants that do not interact with ASK completely fail to repress ASK-induced cell proliferation. Together, these findings demonstrate a functional link between menin and ASK in the regulation of cell proliferation.
doi_str_mv 10.1158/0008-5472.CAN-04-0724
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66882642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66882642</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-408ecdf0f95e6aaa17b6c7e364cd953d2eee367634c137c5c9a7da0e794cb4243</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EoqXwCaBsYOdiO34ky6riJSFYAGvLcSYikDjBTkD8PQ6t6JLVzB2dmZEOQqeULCkV2SUhJMOCK7Zcrx4w4ZgoxvfQnIo0w4pzsY_mf8wMHYXwFqOgRByiWYQUz_Nsjl6uR2eHunOmSWo3gDe_KSlg-AJwyTC2nU_C2PceQohtC652iXFlMpGfZoizrkqecP9qAiTvtYvlGB1Upglwsq2L-OfqeX2L7x9v7tare2w5IQPmJANbVqTKBUhjDFWFtApSyW2Zi7RkADEomXJLU2WFzY0qDQGVc1twxtMFutjc7X33MUIYdFsHC01jHHRj0FJmGZOc_QtSlUkmyASKDWh9F4KHSve-bo3_1pToSbyepOpJqo7iNeF6Eh_3zrYPxqKFcre1NR2B8y1ggjVN5Y2zddhxkhJGpUp_AP2mjKk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17862502</pqid></control><display><type>article</type><title>Functional interaction between tumor suppressor menin and activator of S-phase kinase</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>SCHNEPP, Robert W ; ZHAOYUAN HOU ; HAOREN WANG ; PETERSEN, Clark ; SILVA, Albert ; MASAI, Hisao ; XIANXIN HUA</creator><creatorcontrib>SCHNEPP, Robert W ; ZHAOYUAN HOU ; HAOREN WANG ; PETERSEN, Clark ; SILVA, Albert ; MASAI, Hisao ; XIANXIN HUA</creatorcontrib><description>Multiple endocrine neoplasia type I (MEN1), a hereditary tumor syndrome, is characterized by the development of tumors in multiple endocrine organs. The gene mutated in MEN1 patients, Men1, encodes a tumor suppressor, menin. Overexpression of menin leads to inhibition of Ras-transformed cells. However, it is unclear whether menin is essential for repression of cell proliferation, and if it is, how it inhibits cell proliferation. Here, we show that targeted disruption of the Men1 gene leads to enhanced cell proliferation, whereas complementation of menin-null cells with menin reduces cell proliferation. Moreover, menin interacts with activator of S-phase kinase (ASK), a component of the Cdc7/ASK kinase complex that is crucial for cell proliferation, but does not appear to alter Cdc7 kinase activity in in vitro kinase assays. We identify the COOH terminus of menin as the domain that mediates the specific interaction with ASK. Notably, wild-type menin completely represses ASK-induced cell proliferation, although it does not obviously affect the steady-state cell cycle profile of ASK-infected cells. Interestingly, disease-related COOH-terminal menin mutants that do not interact with ASK completely fail to repress ASK-induced cell proliferation. Together, these findings demonstrate a functional link between menin and ASK in the regulation of cell proliferation.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-04-0724</identifier><identifier>PMID: 15374998</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Cell Cycle - genetics ; Cell Cycle Proteins - antagonists &amp; inhibitors ; Cell Cycle Proteins - metabolism ; Cell Cycle Proteins - physiology ; Cell Division - physiology ; Cells, Cultured ; Humans ; Medical sciences ; Multiple Endocrine Neoplasia Type 1 - genetics ; Mutation ; Pharmacology. Drug treatments ; Protein Subunits ; Protein-Serine-Threonine Kinases - metabolism ; Proto-Oncogene Proteins - antagonists &amp; inhibitors ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins - metabolism ; Proto-Oncogene Proteins - physiology ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 2004-09, Vol.64 (18), p.6791-6796</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-408ecdf0f95e6aaa17b6c7e364cd953d2eee367634c137c5c9a7da0e794cb4243</citedby><cites>FETCH-LOGICAL-c400t-408ecdf0f95e6aaa17b6c7e364cd953d2eee367634c137c5c9a7da0e794cb4243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3343,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16102167$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15374998$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SCHNEPP, Robert W</creatorcontrib><creatorcontrib>ZHAOYUAN HOU</creatorcontrib><creatorcontrib>HAOREN WANG</creatorcontrib><creatorcontrib>PETERSEN, Clark</creatorcontrib><creatorcontrib>SILVA, Albert</creatorcontrib><creatorcontrib>MASAI, Hisao</creatorcontrib><creatorcontrib>XIANXIN HUA</creatorcontrib><title>Functional interaction between tumor suppressor menin and activator of S-phase kinase</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Multiple endocrine neoplasia type I (MEN1), a hereditary tumor syndrome, is characterized by the development of tumors in multiple endocrine organs. The gene mutated in MEN1 patients, Men1, encodes a tumor suppressor, menin. Overexpression of menin leads to inhibition of Ras-transformed cells. However, it is unclear whether menin is essential for repression of cell proliferation, and if it is, how it inhibits cell proliferation. Here, we show that targeted disruption of the Men1 gene leads to enhanced cell proliferation, whereas complementation of menin-null cells with menin reduces cell proliferation. Moreover, menin interacts with activator of S-phase kinase (ASK), a component of the Cdc7/ASK kinase complex that is crucial for cell proliferation, but does not appear to alter Cdc7 kinase activity in in vitro kinase assays. We identify the COOH terminus of menin as the domain that mediates the specific interaction with ASK. Notably, wild-type menin completely represses ASK-induced cell proliferation, although it does not obviously affect the steady-state cell cycle profile of ASK-infected cells. Interestingly, disease-related COOH-terminal menin mutants that do not interact with ASK completely fail to repress ASK-induced cell proliferation. Together, these findings demonstrate a functional link between menin and ASK in the regulation of cell proliferation.</description><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Cell Cycle - genetics</subject><subject>Cell Cycle Proteins - antagonists &amp; inhibitors</subject><subject>Cell Cycle Proteins - metabolism</subject><subject>Cell Cycle Proteins - physiology</subject><subject>Cell Division - physiology</subject><subject>Cells, Cultured</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Multiple Endocrine Neoplasia Type 1 - genetics</subject><subject>Mutation</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Subunits</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Proto-Oncogene Proteins - antagonists &amp; inhibitors</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Proto-Oncogene Proteins - physiology</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtOwzAQRS0EoqXwCaBsYOdiO34ky6riJSFYAGvLcSYikDjBTkD8PQ6t6JLVzB2dmZEOQqeULCkV2SUhJMOCK7Zcrx4w4ZgoxvfQnIo0w4pzsY_mf8wMHYXwFqOgRByiWYQUz_Nsjl6uR2eHunOmSWo3gDe_KSlg-AJwyTC2nU_C2PceQohtC652iXFlMpGfZoizrkqecP9qAiTvtYvlGB1Upglwsq2L-OfqeX2L7x9v7tare2w5IQPmJANbVqTKBUhjDFWFtApSyW2Zi7RkADEomXJLU2WFzY0qDQGVc1twxtMFutjc7X33MUIYdFsHC01jHHRj0FJmGZOc_QtSlUkmyASKDWh9F4KHSve-bo3_1pToSbyepOpJqo7iNeF6Eh_3zrYPxqKFcre1NR2B8y1ggjVN5Y2zddhxkhJGpUp_AP2mjKk</recordid><startdate>20040915</startdate><enddate>20040915</enddate><creator>SCHNEPP, Robert W</creator><creator>ZHAOYUAN HOU</creator><creator>HAOREN WANG</creator><creator>PETERSEN, Clark</creator><creator>SILVA, Albert</creator><creator>MASAI, Hisao</creator><creator>XIANXIN HUA</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20040915</creationdate><title>Functional interaction between tumor suppressor menin and activator of S-phase kinase</title><author>SCHNEPP, Robert W ; ZHAOYUAN HOU ; HAOREN WANG ; PETERSEN, Clark ; SILVA, Albert ; MASAI, Hisao ; XIANXIN HUA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-408ecdf0f95e6aaa17b6c7e364cd953d2eee367634c137c5c9a7da0e794cb4243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Cell Cycle - genetics</topic><topic>Cell Cycle Proteins - antagonists &amp; inhibitors</topic><topic>Cell Cycle Proteins - metabolism</topic><topic>Cell Cycle Proteins - physiology</topic><topic>Cell Division - physiology</topic><topic>Cells, Cultured</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Multiple Endocrine Neoplasia Type 1 - genetics</topic><topic>Mutation</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Subunits</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Proto-Oncogene Proteins - antagonists &amp; inhibitors</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Proto-Oncogene Proteins - physiology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SCHNEPP, Robert W</creatorcontrib><creatorcontrib>ZHAOYUAN HOU</creatorcontrib><creatorcontrib>HAOREN WANG</creatorcontrib><creatorcontrib>PETERSEN, Clark</creatorcontrib><creatorcontrib>SILVA, Albert</creatorcontrib><creatorcontrib>MASAI, Hisao</creatorcontrib><creatorcontrib>XIANXIN HUA</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SCHNEPP, Robert W</au><au>ZHAOYUAN HOU</au><au>HAOREN WANG</au><au>PETERSEN, Clark</au><au>SILVA, Albert</au><au>MASAI, Hisao</au><au>XIANXIN HUA</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional interaction between tumor suppressor menin and activator of S-phase kinase</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2004-09-15</date><risdate>2004</risdate><volume>64</volume><issue>18</issue><spage>6791</spage><epage>6796</epage><pages>6791-6796</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Multiple endocrine neoplasia type I (MEN1), a hereditary tumor syndrome, is characterized by the development of tumors in multiple endocrine organs. The gene mutated in MEN1 patients, Men1, encodes a tumor suppressor, menin. Overexpression of menin leads to inhibition of Ras-transformed cells. However, it is unclear whether menin is essential for repression of cell proliferation, and if it is, how it inhibits cell proliferation. Here, we show that targeted disruption of the Men1 gene leads to enhanced cell proliferation, whereas complementation of menin-null cells with menin reduces cell proliferation. Moreover, menin interacts with activator of S-phase kinase (ASK), a component of the Cdc7/ASK kinase complex that is crucial for cell proliferation, but does not appear to alter Cdc7 kinase activity in in vitro kinase assays. We identify the COOH terminus of menin as the domain that mediates the specific interaction with ASK. Notably, wild-type menin completely represses ASK-induced cell proliferation, although it does not obviously affect the steady-state cell cycle profile of ASK-infected cells. Interestingly, disease-related COOH-terminal menin mutants that do not interact with ASK completely fail to repress ASK-induced cell proliferation. Together, these findings demonstrate a functional link between menin and ASK in the regulation of cell proliferation.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>15374998</pmid><doi>10.1158/0008-5472.CAN-04-0724</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 2004-09, Vol.64 (18), p.6791-6796
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_66882642
source MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals
subjects Antineoplastic agents
Biological and medical sciences
Cell Cycle - genetics
Cell Cycle Proteins - antagonists & inhibitors
Cell Cycle Proteins - metabolism
Cell Cycle Proteins - physiology
Cell Division - physiology
Cells, Cultured
Humans
Medical sciences
Multiple Endocrine Neoplasia Type 1 - genetics
Mutation
Pharmacology. Drug treatments
Protein Subunits
Protein-Serine-Threonine Kinases - metabolism
Proto-Oncogene Proteins - antagonists & inhibitors
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins - metabolism
Proto-Oncogene Proteins - physiology
Tumors
title Functional interaction between tumor suppressor menin and activator of S-phase kinase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T15%3A25%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20interaction%20between%20tumor%20suppressor%20menin%20and%20activator%20of%20S-phase%20kinase&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=SCHNEPP,%20Robert%20W&rft.date=2004-09-15&rft.volume=64&rft.issue=18&rft.spage=6791&rft.epage=6796&rft.pages=6791-6796&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/10.1158/0008-5472.CAN-04-0724&rft_dat=%3Cproquest_cross%3E66882642%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17862502&rft_id=info:pmid/15374998&rfr_iscdi=true